AI-designed drug rentosertib cut patients' biological age by up to 6 years in 4-week Phase 2 study
Polymarket · x · 2026-09-08
In a small Phase 2 study, the experimental AI-designed drug rentosertib reduced patients' measured biological age by as much as 6 years after just 4 weeks.
The data is early-stage and small-sample, but it is a notable signal for AI-driven drug design intersecting with longevity research.
Related event: AI-Designed IPF Drug Rentosertib Shows Biological Age Reversal in Trial(18 posts)→
More from Apps
- Grok Impressions: Delegating Forms, Shopping and Payments to Grok Bot — XFreeze · 2026-10-27
- Analyst Ben Bajarin spends a weekend with iPhone Duo: 'most productive iPhone' — BenBajarin · 2026-10-27
- Vovy launches a cursor-following voice agent for Mac, free tier gives 100 credits/mo — Scobleizer · 2026-10-27
- FluidVoice launches premium on-device dictation, taking aim at WisprFlow and Willow — Scobleizer · 2026-10-27
- A heuristic for judging app value: look at how someone orders their iPhone share sheet — signulll · 2026-10-27
- Sojo soft-launches: build playable games inside X from a single prompt — jaivinwylde · 2026-10-27